๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Low p27 expression correlates with poor prognosis for patients with oral tongue squamous cell carcinoma

โœ Scribed by Hiroyuki Mineta; Katsutoshi Miura; Ikuko Suzuki; Satoru Takebayashi; Hajime Amano; Keisuke Araki; Hidekazu Harada; Keiichi Ichimura; Johan P. Wennerberg; Michael R. Dictor


Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
136 KB
Volume
85
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Background:

P27, a cyclin-dependent kinase inhibitor, regulates progression from g1 to s phase. there have been a few clinical reports of low p27 expression associated with poor survival among patients with cancer; however, there have been no reports of such an association in cases of head and neck cancer. the authors investigated whether p27 expression in patients with oral tongue squamous cell carcinoma was associated with their prognosis.

Methods:

Ninety-four patients with oral tongue squamous cell carcinoma were analyzed. the authors performed p27 immunohistochemistry on all patients and western blot analysis on 19 available patients. cox proportional hazards regression analysis that included gender, history of smoking and alcohol usage, presence of multiple primary cancers, stage, histologic grade, and p27 status was used to identify the multivariate predictive value of prognostic factors.

Results:

Twenty-six patients had high p27 expression (> or =50% tumor cell nuclei positive), and 68 patients had low p27 expression (<50%) by immunohistochemistry. in those with low p27 expression, n(+) and advanced t (t3 or t4) were significantly higher than in those with high p27 expression (p = 0.02 and 0.04). the 5-year survival rate in the low p27 group was 44%, whereas that in the high p27 group was 68%, indicating a significant difference (p = 0.04). p27 expression was inferred from western blot analysis, and an arbitrary quantity (<1, 1-5, or > or =5) from the ratio of tumor to normal tissue density was used to characterize, resulting in 8 (42%), 3 (16%), and 8 (42%) patients in the low (<1-fold), intermediate (1-5-fold), and high (> or =5-fold) groups, respectively. results of immunohistochemical analysis for p27 were significantly correlated with those of western blot analysis (p = 0.02). multivariate analysis revealed that low intensity of p27 expression and advanced stage (stage iii or iv) were predictors of reduced survival (p = 0.02 and 0.001).

Conclusions:

Low p27 expression was associated with increasing lymph node metastasis and stage of tumor and resulted in a poor prognosis for patients with oral tongue squamous cell carcinoma. p27 is apparently a significant predictor of survival.


๐Ÿ“œ SIMILAR VOLUMES


Expression of tissue inhibitor of matrix
โœ Tomokazu Yoshizaki; Yumiko Maruyama; Hiroshi Sato; Mitsuru Furukawa ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 321 KB ๐Ÿ‘ 2 views

Matrix metalloproteinase 2 (MMP-2) plays a crucial role in invasion and metastasis of malignant tumors. Membrane type 1-MMP (MT1-MMP) was originally identified as an activator of MMP-2. Tissue inhibitor of MMP-2 (TIMP-2) was identified as an inhibitor of MMP-2 and MT1-MMP. However, TIMP-2 was report

Expression of thymidine phosphorylase as
โœ Jun-ichirou Arima; Yoshiharu Imazono; Yuji Takebayashi; Kenryu Nishiyama; Tsutom ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 334 KB ๐Ÿ‘ 2 views

## Background: Thymidine phosphorylase (tp), which is identical to platelet-derived endothelial cell growth factor (pd-ecgf), stimulates chemotaxis of endothelial cells and is involved in the angiogenesis of human solid tumors. ## Methods: The activity and expression of tp were examined in human

Expression of p53 in oral squamous cell
โœ Saman Warnakulasuriya; Thierry Soussi; Rehana Maher; Newell Johnson; Mahvash Tav ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 189 KB ๐Ÿ‘ 2 views

Around 50% of head and neck cancers are known to have aberrations of the p53 gene. Overexpression of the mutant p53 protein can induce a specific humoral response in cancer patients. Matched saliva, serum, and tissue samples from 26 patients with histologically confirmed oral squamous and verrucous